MSK Pharma Group Honored as Finalist in the Grand Prix of Medium-Sized Businesses

Bensheim, September 28, 2026. MSK Pharma Group has been recognized as a finalist in the prestigious Grand Prix of Medium-Sized Businesses (“Großer Preis des Mittelstandes”). The award, presented by the Oskar Patzelt Foundation, honors companies that demonstrate outstanding entrepreneurial responsibility, innovation, sustainable development, and social commitment.

Being named a finalist is a significant achievement within the competition and highlights the successful growth and development of MSK Pharma Group. As a full-service provider for the pharmaceutical and healthcare industry, the company group offers a comprehensive range of services in pharmaceutical logistics, pharmaceutical packaging, quality management, and consulting, supporting customers throughout the entire pharmaceutical value chain.

“Being recognized as a finalist in the Grand Prix of Medium-Sized Businesses is a special acknowledgment of MSK Pharma Group’s development and achievements. It confirms our commitment to delivering reliable and innovative solutions for the pharmaceutical and healthcare industry. Above all, this recognition belongs to our entire team, whose dedication and expertise drive our success every day,” says Simon Heß, CEO of MSK Pharma Group.

The Grand Prix of Medium-Sized Businesses is considered one of Germany’s most prestigious business awards. Companies cannot apply for the competition themselves but must be nominated by third parties. The evaluation criteria include overall business development, job creation and retention, innovation and modernization, regional engagement, and the company’s role in society and the economy.

For many years, MSK Pharma Group has combined sustainable growth with a strong commitment to quality and responsible business practices. Through continuous investment in modern processes, innovative solutions, and highly qualified professionals, the company helps meet the evolving demands of the pharmaceutical and healthcare sectors.

MSK Pharma Group views its recognition as a finalist as both an honor and a motivation to continue pursuing its strategic path while contributing to a high-performing and reliable healthcare system.

About MSK Pharma Group

MSK Pharma Group is a full-service provider for the pharmaceutical and healthcare industry, offering expertise in pharmaceutical logistics, pharmaceutical packaging, quality management, and consulting. Through its specialized services, the company supports customers across the entire pharmaceutical value chain, with a strong focus on quality, reliability, and long-term partnerships.